RO.CH

327.6

+1.11%↑

NOVN.CH

120.76

-0.74%↓

LONN.CH

527.2

+3.33%↑

STMN.CH

86.42

+4.02%↑

BANB.CH

72.75

+8.42%↑

RO.CH

327.6

+1.11%↑

NOVN.CH

120.76

-0.74%↓

LONN.CH

527.2

+3.33%↑

STMN.CH

86.42

+4.02%↑

BANB.CH

72.75

+8.42%↑

RO.CH

327.6

+1.11%↑

NOVN.CH

120.76

-0.74%↓

LONN.CH

527.2

+3.33%↑

STMN.CH

86.42

+4.02%↑

BANB.CH

72.75

+8.42%↑

RO.CH

327.6

+1.11%↑

NOVN.CH

120.76

-0.74%↓

LONN.CH

527.2

+3.33%↑

STMN.CH

86.42

+4.02%↑

BANB.CH

72.75

+8.42%↑

RO.CH

327.6

+1.11%↑

NOVN.CH

120.76

-0.74%↓

LONN.CH

527.2

+3.33%↑

STMN.CH

86.42

+4.02%↑

BANB.CH

72.75

+8.42%↑

Kodu・Aktsiate loetelu・Sandoz Group AG

Sandoz Group AG

Avatud

67.26 3.13

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

64.76

Max

68.08

Põhinäitajad
By Trading Economics
Sissetulek	160M 537M
Müük	641M 5.9B
P/E Sektori keskmine	38.323 66.418
Aktsiakasum	0.87
Dividenditootlus	1.57
Kasumimarginaal	9.093
Töötajad	22,356
EBITDA	427M 1B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+6.83% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	1.57% 2.36%
Järgmine tulemuste avaldamine	29. apr 2026

Turustatistika
By TradingEconomics
Turukapital	-1.2B 28B
Eelmine avamishind	64.13
Eelmine sulgemishind	67.26

Sandoz Group AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. okt 2025, 09:10 UTC

Kuumad aktsiad

Stocks to Watch Thursday: HSBC, PepsiCo, MP Materials -- WSJ

28. juuli 2025, 10:51 UTC

Market Talk

U.S.-EU Tariff Deal, Earnings Could Keep Pharma Rally Going -- Market Talk

15. apr 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Sandoz Group AG Prognoos

Hinnasiht

By TipRanks

6.83% tõus

12 kuu keskmine prognoos

Keskmine 71.167 CHF 6.83%

Kõrge 80 CHF

Madal 62 CHF

Põhineb 7 Wall Streeti analüütiku instrumendi Sandoz Group AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

7 ratings

Osta

Hoia

Müü

Põhineb 7 analüütiku instrumendi Sandoz Group AG aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.